Results

Total Results: 185 records

Showing results for "bmi screening".
Users also searched for: chlamydia

81. Primary-Healthcare-Spending-Draft-Tech-Brief-Appendix-G (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/primary-healthcare-spending-draft-tech-brief-appendix-g.xlsx
    June 01, 2023 - & Assessments Primary Care G0103 PSA Screening 33% X X X X X Screenings & Assessments OB/GYN … Services For A Single High-Risk Disease Clinical Staff 20% X X X Care Management Primary Care G8420 BMI … & Assessments Primary Care G0104 Colorectal cancer screening, flexible sigmoidoscopy 7% X Screenings … 7% X Screenings & Assessments Primary Care G0106 Colorectal cancer screening, alternative to G0104 … Behavioral Health H0002 Behavioral Health Screening To Admit To Treatment Program 7% X Screenings &

82. Appendices (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-clinician-level-strategies-appendixes-draft-tech-brief.pdf
    February 01, 2023 - Patient Researcher/Admin Standard/usual care Clinical outcomes HbA1c, lipids, blood pressure, BMI … Health Center’s Diabetic Obesity Weight Loss Pilot Program- Standard/usual care  Clinical outcomes BMI … Pre-post Process of care Documentation of screening, screening positive for unhealthy drinking, … management, healthcare consultations) 6 months Patient CHW Pre-post Process of care Weight, BMI … Intervention to Improve Awareness, Knowledge, and Utilization of Breast, Cervical, and Colorectal Cancer Screenings

83. Disposition of Comments Report for Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
    October 23, 2014 - Hard to imagine PET being used for screening/surveillance. … For example, in the diagnosis of HCC, BMI, Fatty Liver and Depth of lesions in the liver are potentially … As shown in Table 6, in studies of US that evaluated effects of lesion depth or BMI, there was no effect … of care despite high quality data to support it and a randomized trial of screening versus no screening … is impractical because screening has become standard of care.

84. Strategies-Integrating-Behavioral-Health-Evidence-Tables (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/strategies-integrating-behavioral-health-evidence-tables.xlsx
    January 01, 2014 - Mean (SD) HbA1c: 8.0 (1.9) vs. 7.7 (1.9), p=0.67, adjusted mean difference -0.11 (SE 0.24) Mean (SD) BMI … services (APSS) Comparator 2: Wellness and recovery center (WRC) 132 110 108 Compliance with cancer screenings … Change in BMI 3 months: −0.11 vs. −0.05, p=0.049 6 months: −0.11, p=0.0006 vs. −0.06, p=0.08 BMI remained … BMI decreased with Specialist tele-visits for comparison and was significantly different from baseline … BMI did not differ between groups at the end of the 12-month study.

85. Behavioral Programs for Diabetes Mellitus | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/research-protocol
    June 05, 2014 - Type 1 diabetes (Key Questions 1-4) PICOTS Criteria BMI = body mass index; HbA 1c = hemoglobin … medication Clinical outcomes Glycemic control (HbA 1c ) Change in body composition (i.e., weight, BMI … Type 2 diabetes (Key Questions 5-6) PICOTS Criteria BMI = body mass index; HbA 1c = hemoglobin … medication Clinical outcomes Glycemic control (HbA 1c ) Change in body composition (i.e., weight, BMI … Abstract and full-text screening will be performed as described above.

86. Dispostion of Comments Report for Screening for Hepatitis C Virus Infection in Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
    November 27, 2012 - compared with no screening (or comparing different screening approaches) in nonpregnant or pregnant … of high -risk populations should not receive routine HCV screenings; however, none of the key questions … therapies that depends to a large extent on follow-up regarding ETOH and working towards a normal BMI … Rather than explore screening vs. no screening, it would be more useful to compare different screening … ), no single screening tool is established as the right tool to use for screening.

87. App-D-Surv-Report-2-Noninvasive-Nonpharma 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma_0.xlsx
    January 01, 2022 - half the days of the last 6 months and 1-week average pain intensity score of 4 of 10 or greater at screening … Duration of symptoms: 180 vs. 240 months Pain etiology/type or diagnostic classification: LBP Mean BMI … within 12 weeks before enrollment; systemic or intra-articular corticosteroid use within 60 days of the screening … B Age: 65 vs. 66 Female: 48% vs. 54% BMI: 27.5 (4.9) vs. 26.9 (4.9) Baseline WOMAC Pain: 3.4 (1.4) vs … Adverse event (AE) Attention control (AC) Beck Depression Inventory (BDI) Body Mass Index (BMI)

88. App-D-Surv-Report-3-Noninvasive-Nonpharma 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
    January 01, 2022 - half the days of the last 6 months and 1-week average pain intensity score of 4 of 10 or greater at screening … Duration of symptoms: 180 vs. 240 months Pain etiology/type or diagnostic classification: LBP Mean BMI … within 12 weeks before enrollment; systemic or intra-articular corticosteroid use within 60 days of the screening … B Age: 65 vs. 66 Female: 48% vs. 54% BMI: 27.5 (4.9) vs. 26.9 (4.9) Baseline WOMAC Pain: 3.4 (1.4) vs … Adverse event (AE) Attention control (AC) Beck Depression Inventory (BDI) Body Mass Index (BMI)

89. Disposition of Comments for Efficacy and Safety of Screening for Postpartum Depression (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
    May 01, 2013 - ES-3, l. 16-18] Change screening “of” to screening “for”. … What is "improved screening?" … (Similar situation for 1st trimester BMI). … screening results. … screening.

90. Breast Reconstruction After Mastectomy | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/breast-reconstruction-mastectomy/protocol
    June 18, 2020 - Duplicate citations will be removed prior to screening. … software to enable title and abstract screening. … The team will conduct two or more rounds of pilot screening. … assessing for the presence of potential confounding in studies, we will consider as age, body mass index (BMI … Society of Plastic Surgeons BIA-ALCL = breast implant-associated anaplastic large cell lymphoma BMI

91. Research Protocol: Breast Reconstruction After Mastectomy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-reconstruction-mastectomy-protocol.pdf
    April 09, 2020 - Duplicate citations will be removed prior to screening. … The team will conduct two or more rounds of pilot screening. … relevant articles relatively early in the abstract screening process. … assessing for the presence of potential confounding in studies, we will consider as age, body mass index (BMI … American Society of Plastic Surgeons BIA-ALCL breast implant-associated anaplastic large cell lymphoma BMI

92. Cer-238-Cervical-Ripening-Appendix-E-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-238-cervical-ripening-appendix-e-2.xlsx
    January 01, 2017 - following an adverse fetal outcome, leading to exclusion of women with diet-controlled diabetes or BMI … following an adverse fetal outcome, leading to exclusion of women with diet-controlled diabetes or BMI … prior induction, lethal fetal anomaly, nonreassuring FHR; Baseline similar for PCFs except parity; BMI … NICU admission) -Transient tachypnea: 0.78% (1/129, required NICU admission) -Failed pulse oximetry screening … -transient tachypnea, reparatory distress, arterial cord blood gas acidemia, failed pulse oximetry screening

93. Comparative Effectiveness of Terbutaline Pump for the Prevention of Preterm Birth | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/preterm-birth-terbutaline-pump/research-protocol
    August 05, 2010 - Table 1: Screening Criteria Study Characteristic Of Interest Not of interest Patient population … Level 1 screening will entail a broad screen based on item titles and/or abstracts, as available. … The full-text of all items passing Level 1 screening will be retrieved for Level 2 screening: an ascertainment … rest), , presence or absence of recurrent preterm labour prior to intervention, and body mass index (BMI … length, cervical effacement, cervical position, cervical consistency, cervical station, Bishop’s Score, BMI

94. Obesity (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Body mass index (BMI), according to the National Institutes of Health, is a measure of an individual … BMI is significantly correlated to an individual’s body-fat percentage and is used as an easy measure … with a BMI of 35 kg/m2 or more to be recommended for surgery.13 Therefore, ReShape Duo will likely

95. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/surveillance-report-3-noninvasive-nonpharma.pdf
    August 01, 2022 - Studies included by either reviewer were retrieved for full-text screening. … patient education; (3) clinician and patient values and preferences related to opioids; (4) urine drug screening … plans Patient education Clinician and patient values and preferences related to opioids Urine drug screening … 5 mg tenoxicam for the pericarotid region 7 days 77 patients aged 36±17.8 years, 42.1% female, BMI … ED Dexketoprofen IV, 50 mg, once over 5 minutes 7 days 77 patients aged 36±17 years, 43.1% female, BMI

96. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - Studies included by either reviewer were retrieved for full-text screening. … patient education; (3) clinician and patient values and preferences related to opioids; (4) urine drug screening … plans Patient education Clinician and patient values and preferences related to opioids Urine drug screening … 5 mg tenoxicam for the pericarotid region 7 days 77 patients aged 36±17.8 years, 42.1% female, BMI … ED Dexketoprofen IV, 50 mg, once over 5 minutes 7 days 77 patients aged 36±17 years, 43.1% female, BMI

97. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/surveillance-report-3-noninvasive-nonpharma.pdf
    August 01, 2022 - Studies included by either reviewer were retrieved for full-text screening. … patient education; (3) clinician and patient values and preferences related to opioids; (4) urine drug screening … plans Patient education Clinician and patient values and preferences related to opioids Urine drug screening … 5 mg tenoxicam for the pericarotid region 7 days 77 patients aged 36±17.8 years, 42.1% female, BMI … ED Dexketoprofen IV, 50 mg, once over 5 minutes 7 days 77 patients aged 36±17 years, 43.1% female, BMI

98. Acute Treatments for Episodic Migraine: Surveillance Report 3 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - Studies included by either reviewer were retrieved for full-text screening. … patient education; (3) clinician and patient values and preferences related to opioids; (4) urine drug screening … plans Patient education Clinician and patient values and preferences related to opioids Urine drug screening … 5 mg tenoxicam for the pericarotid region 7 days 77 patients aged 36±17.8 years, 42.1% female, BMI … ED Dexketoprofen IV, 50 mg, once over 5 minutes 7 days 77 patients aged 36±17 years, 43.1% female, BMI

99. Treatment of Osteoarthritis of the Knee: An Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/osteoarthritis-knee-update/research-protocol
    June 16, 2016 - DistillerSR™ software will be used for screening, abstraction, reconciliation, and tracking. … members of the TEP, peer reviewers, or public reviewers will be obtained and will undergo the same screening … less than 50), those with only early stage or mild disease, those enrolling participants with mean BMI … of Orthopaedic Surgery ACR American College of Rheumatology ADL Activities of Daily Living BMI … AAOS: suggests weight loss for patients with symptomatic osteoarthritis of the knee OAK and a BMI

100. Project Name: (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
     October 25, 2011 - In contrast, screening questionnaires generally performed poorly. … tests compare in different subgroups of patients, based on: race, gender, body mass index (BMI … relied on studies with high risk groups predominantly males with a mean age of about 50 years, and a BMI … tests compare in different subgroups of patients, based on: race, gender, body mass index (BMI … tests compare in different subgroups of patients, based on: race, gender, body mass index (BMI